Trials / Completed
CompletedNCT05162339
Inflammatory Bowel Disease and Thromboembolic Events
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 149 (actual)
- Sponsor
- Centro Hospitalar Tondela-Viseu · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective was to demonstrate the existence and importance of hypercoagulability in patients with IBD, by determining the prevalence of changes in coagulation parameters and evaluating the impact of these changes on the occurrence of thromboembolic events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention was made | No intervention was made |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2020-04-30
- Completion
- 2020-04-30
- First posted
- 2021-12-17
- Last updated
- 2021-12-17
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT05162339. Inclusion in this directory is not an endorsement.